These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3137461)

  • 21. Low-dose human cytomegalovirus infection of human fibroblast cultures induces lymphokine-activated killer cell resistance: interferon-beta-mediated target cell protection does not correlate with up-regulation of HLA class I surface molecules.
    Hamprecht K; Steinmassl M
    Immunology; 1994 Jun; 82(2):171-7. PubMed ID: 7927485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of gamma interferon on the expression of class I MHC antigens on fresh leukemic cells and their susceptibility to lysis by lymphokine activated killer cells.
    Haridas V; Sarin A; Anandhi R; Kochupillai V; Saxena RK
    Indian J Cancer; 1994 Jun; 31(2):96-102. PubMed ID: 7927456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon-gamma-treated K562 target cells distinguish functional NK cells from lymphokine-activated killer (LAK) cells.
    Powell J; Stone J; Chan WC; Yang ZD; Leatherbury A; Sell KW; Wiktor-Jedrzejczak W; Ahmed-Ansari A
    Cell Immunol; 1989 Feb; 118(2):250-64. PubMed ID: 2491960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different susceptibility of cervical keratinocytes containing human papillomavirus to cell-mediated cytotoxicity.
    Wu R; Coleman N; Stanley M
    Chin Med J (Engl); 1996 Nov; 109(11):854-8. PubMed ID: 9275369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells.
    Zennadi R; Abdel-Wahab Z; Seigler HF; Darrow TL
    Cell Immunol; 2001 Jun; 210(2):96-105. PubMed ID: 11520076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells.
    Komatsu F; Kajiwara M
    Oncol Res; 1998; 10(10):483-9. PubMed ID: 10338151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential gamma-interferon response of human colon carcinoma cells: inhibition of proliferation and modulation of immunogenicity as independent effects of gamma-interferon on tumor cell growth.
    Pfizenmaier K; Bartsch H; Scheurich P; Seliger B; Ucer U; Vehmeyer K; Nagel GA
    Cancer Res; 1985 Aug; 45(8):3503-9. PubMed ID: 3160456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon-gamma-induced alterations of monocyte susceptibility to lysis by autologous lymphokine-activated killer (LAK) cells.
    Djeu JY; Blanchard DK
    Int J Cancer; 1988 Sep; 42(3):449-54. PubMed ID: 3138195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clones derived from human natural killer cells are susceptible to lysis by human interleukin-2-activated killer cells.
    Fujiwara T; Loudon WG; Grimm EA
    Lymphokine Cytokine Res; 1993 Feb; 12(1):45-8. PubMed ID: 8096153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human oncogene-transfected tumor cells display differential susceptibility to lysis by lymphokine-activated killer cells (LAK) and natural killer cells.
    Lanza LA; Wilson DJ; Ikejiri B; Roth JA; Grimm EA
    J Immunol; 1986 Oct; 137(8):2716-20. PubMed ID: 3489774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.
    Reiter Z
    Crit Rev Immunol; 1993; 13(1):1-34. PubMed ID: 8466640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lowered susceptibility of K-562 cells treated with gamma interferon in serum-free medium to natural killer cell-mediated cytolysis.
    Ichiki AT; Sugantharaj DG; Hudson CS; Gerard DA; Barnhill MA; Bamberger EG; Wust CJ; Fuhr JE; Lozzio CB
    Nat Immun Cell Growth Regul; 1988; 7(5-6):297-304. PubMed ID: 3146698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncolytic activity of NK cells against SW-756 squamous cervical carcinoma cell line: role of interferons alpha and gamma and CD54 adhesion molecule in oncolysis.
    Cristoforoni PM; Lotzová E; Cook KR; Chuang LT; Morris M; Grossi CE; Wharton JT
    Gynecol Oncol; 1994 Mar; 52(3):365-72. PubMed ID: 7512522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of TNF-alpha and IFN-alpha on the proliferation and cytotoxicity of lymphokine-activated killer cells in patients with bladder cancer.
    Wang Z; Cheng Y; Zheng R; Qin D; Liu G
    Chin Med J (Engl); 1997 Mar; 110(3):180-3. PubMed ID: 9594335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of immunotherapy with allogeneic lymphokine-activated killer cells and recombinant interleukin 2 on established pulmonary and hepatic metastases in mice.
    Shiloni E; Lafreniere R; Mulé JJ; Schwarz SL; Rosenberg SA
    Cancer Res; 1986 Nov; 46(11):5633-40. PubMed ID: 3489526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human recombinant IL-4 suppresses the induction of human IL-2 induced lymphokine activated killer (LAK) activity.
    Brooks B; Rees RC
    Clin Exp Immunol; 1988 Nov; 74(2):162-5. PubMed ID: 3265652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obligatory role of IFN-gamma in induction of lymphokine-activated and T lymphocyte killer activity, but not in boosting of natural cytotoxicity.
    Giovarelli M; Santoni A; Jemma C; Musso T; Giuffrida AM; Cavallo G; Landolfo S; Forni G
    J Immunol; 1988 Oct; 141(8):2831-6. PubMed ID: 3139768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of class I MHC antigen levels on some human tumor cell lines with susceptibility to LAK cells and performance in cold target inhibition assays.
    Haridas V; Saxena RK
    Cell Immunol; 1995 Apr; 161(2):256-61. PubMed ID: 7697736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene.
    Maio M; Altomonte M; Tatake R; Zeff RA; Ferrone S
    J Clin Invest; 1991 Jul; 88(1):282-9. PubMed ID: 1905328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of major histocompatibility complex class I antigens in modulating the performance of murine tumour cells in cold target competition assays.
    Haridas V; Saxena RK
    Immunology; 1995 Jan; 84(1):86-90. PubMed ID: 7890307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.